Brief: Aquestive Therapeutics, Inc. Q3 Income From Operations USD -11.479 Million
05/11/2025 21:01
Nov 05 (Reuters) - Aquestive Therapeutics, Inc. Q3 net income USD -15.446 million. Q3 pretax profit USD -15.446 million Q3 revenue USD 12.807 million vs. IBES estimate USD 12.7 million Q3 adjusted EBITDA USD -8.563 million vs. IBES estimate USD -10.7 million
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing
Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income
Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film
Aquestive misses Q4 revenue estimates, EBITDA loss widens
Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million